chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I received my vaccine 11/19/2021 and 6 months later 4 days after attending my daughter's graduation I got a head ache and started feeling like I was coming down with a cold with a sore throat. That night I had chills and was feeling feverish. I had a low grade fever of 100 degrees. I was chilled hot/cold. The next morning I took an at home Covid test and it was immediately positive. I made an apt with my doctor and had a telehealth apt.
super sleepy; Had the normal arm stuff; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (super sleepy) and VACCINATION COMPLICATION (Had the normal arm stuff) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011M20A and 001B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SOMNOLENCE (super sleepy) and VACCINATION COMPLICATION (Had the normal arm stuff). At the time of the report, SOMNOLENCE (super sleepy) and VACCINATION COMPLICATION (Had the normal arm stuff) outcome was unknown.      No concomitant medications were reported.  No treatment medications were reported.   This case was linked to MOD-2021-320240 (Patient Link).
The vaccine was administered on 5/15/17. On 5/16/17 a small reaction developed. By 5/17/17, a red welt developed on the site of administration. The welt was approximately 6" x 2". Referred patient to PCP.
This spontaneous report was received from a registered nurse and refers to a 22 year old patient of unknown gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 17-JAN-2017, the patient was vaccinated with an improperly stored dose of GARDASIL 9 (route and site of administration, lot # and expiration date were not reported). There was no adverse effect reported. This is one of several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1704USA002249: US-009507513-1704USA002250:
Pt had 1st Shingrix 8yrs ago and never got second; This case was reported by a other health professional via (Shingrix GSK Chatbot) interactive digital media and described the occurrence of incomplete course of vaccination in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received first dose on an unknown date 8 years before the time of reporting).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive the second dose of Shingrix, which led to incomplete course of vaccination. The patient enquired if he had the need to restart schedule or in other words one or two doses.
feverish; chills; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (feverish) and CHILLS (chills) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included SARS-CoV-2 infection in October 2020.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced CHILLS (chills). On 12-Mar-2021, the patient experienced PYREXIA (feverish). At the time of the report, PYREXIA (feverish) and CHILLS (chills) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information not provided. Concomitant medications were not provided.
Patient experienced swelling around injection site for about 5 days, patient had stomach pains, headache, intense itching all over body, reaction lasted about 2 weeks. Patient still has itching at nighttime, and slight headaches.
Pt states felt as if throat was swelling. Had emesis, and felt better. Face covered with urticarial hives, spreading down arms. Went to ER given prednisone and antihistamines.
Onset of tachycardia was 8:30pm on 1/12/21 with a noted HR of 164 and SR. Went to ER and had HR of 171 upon arriving to triage window. EKG said Sinus Tachycardia. Admitted to observation station with telemetry to monitor HR. HR normalized around 100 when up and walking at 10:45am on 1/13/21.
Muscle Aches; Low grade Fever 98.8 Fahrenheit; May Have Sinus Infection; Nasal discharge (green and blody); sneezing a little; Tired; This spontaneous case was reported by a consumer and describes the occurrence of SINUSITIS (May Have Sinus Infection), SNEEZING (sneezing a little), RHINORRHOEA (Nasal discharge (green and blody)), MYALGIA (Muscle Aches) and PYREXIA (Low grade Fever 98.8 Fahrenheit) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 015M20A and 0416O20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Muscle ache on 01-Jan-2021.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Feb-2021, the patient experienced SNEEZING (sneezing a little) and FATIGUE (Tired). On 16-Feb-2021, the patient experienced SINUSITIS (May Have Sinus Infection), RHINORRHOEA (Nasal discharge (green and blody)) and PYREXIA (Low grade Fever 98.8 Fahrenheit). On an unknown date, the patient experienced MYALGIA (Muscle Aches). At the time of the report, SINUSITIS (May Have Sinus Infection), SNEEZING (sneezing a little), RHINORRHOEA (Nasal discharge (green and blody)), PYREXIA (Low grade Fever 98.8 Fahrenheit) and FATIGUE (Tired) outcome was unknown and MYALGIA (Muscle Aches) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Feb-2021, Body temperature: 98.8 DF.         Concomitant medications were not provided. The patient received acetaminophen for muscle ache.
Developed severe itching and rash looking like General Dermatitis after 2nd dose of vaccine.  Possible milder reaction of itching and light rash after 1st dose,
Administered 2nd dose in left arm and the needle was faulty and the dose spilled out of syringe. It definitely appeared that patient missed the full dose so I immediately administered another dose in the right arm as indicated in guidelines. Notified patient of the defective syringe leading to missed dose which is why additional vaccine was given in Right arm and she was very understanding.
Patient says he had this response after receiving both vaccines on 10/2/20: nausea, malaise, sore red arm, itchiness around injection sites. His doctor told him it was a robust immune response. No rash, hives, or trouble breathing.
Movements reduced; Stiff neck; ache; chills; fever; headache; Neck pain; Difficulty in standing; Sitting disability; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (Stiff neck), PAIN (ache), CHILLS (chills), PYREXIA (fever) and HEADACHE (headache) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011L20A and 011M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No specified medical history has been reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Mar-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (Stiff neck), PAIN (ache), CHILLS (chills), PYREXIA (fever) and HEADACHE (headache). On an unknown date, the patient experienced NECK PAIN (Neck pain), DYSSTASIA (Difficulty in standing), SITTING DISABILITY (Sitting disability) and HYPOKINESIA (Movements reduced). On 19-Mar-2021, MUSCULOSKELETAL STIFFNESS (Stiff neck) had resolved. At the time of the report, PAIN (ache), CHILLS (chills), PYREXIA (fever) and HEADACHE (headache) outcome was unknown and NECK PAIN (Neck pain), DYSSTASIA (Difficulty in standing), SITTING DISABILITY (Sitting disability) and HYPOKINESIA (Movements reduced) had resolved.            No concomitant medications were reported.  No treatment information was reported.   Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2021: Significant follow-up  contain patient detail, suspect dose 1 detail, vaccine facility detail, event detail updated and new events are added.
01/09 shortly after vaccine for right arm soreness and right eye swelling, about 6 hours after vaccine 01/09 body aches, headache couldn?t move neck due to stiffness; 01/10 left arm soreness, armpit pulsation, fever range 102 F,; 01/11 vomiting. seasonal allergy eye drops for right eye swelling (went away), Benadryl 50 mg.; ibuprofen and Tylenol around the clock starting 01/09 to present day, 01/11/2021
Terrible head pressure Oct 19 8 hrs after shot. Feeling very sick 8 PM - next day heart palpitations. Oct 25 Headache, sick.
Pneumonia; Chronic ischemic heart disease; Recurrent acute conjunctivitis; Bilateral sensorineural hearing loss; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient of unspecified age.  No information was provided regarding medical history, concurrent conditions, or concomitant medications.    In or around 17-MAR-2016, the patient was inoculated with zoster vaccine live (ZOSTAVAX) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). On an unknown date (reported as shortly after receiving zoster vaccine live (ZOSTAVAX)), the patient suffered acute conjunctivitis, nausea and shorthness of breath. Later the patient was hospitalized and was diagnosed with pneumonia and chronic ischemic heart disease (myocardial ischaemia). The patient also started to experience tinnitus, dizziness and vértigo, subsequently he was diagnosed with bilateral sensorineural hearing los(deafness neurosensory) on an unknown date.  As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient's symptoms have resulted in physical limitations not present prior to using the product. The patient also experienced mental and emotional distress due to resulting physical limitations and seriousness of her condition.  As a result of zoster vaccine live (ZOSTAVAX), the patient sustained severe and permanent personal injuries.  Further, as a tragic consequence, the patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury.  As a direct and proximate result, the patient suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of the events were considered not recovered/not resolved.  The events were considered related to zoster vaccine live (ZOSTAVAX).  All the events were considered to be disabling.  Upon internal review, the events pneumonia, myocardial ischaemia and deafness neurosensory were considered to be medically significant.
Started with constant pain in left arm around 5 pm the evening of the vaccine. Swelling from injection sight of Left deltoid that radiated down arm to right above the elbow. Currently 2 days later, redness has radiated down the left side of the arm past elbow. Client reports pain is better this am. Encouraged client to apply cool compresses and can use anti-itch cream to area if itching occurs. Can take acetaminophen for pain if needed.
2nd dose in series. First vaccine only side effect  was slight injection site pain for 3 days.  2nds dose caused significant pain and several areas of redness, swelling, pain and warm to touch below injection. Also experienced flu- like symptoms approx 24 hours after vaccine that lasted for 24 hours. unable to complete daily responsibilities.
Severe dizzy spells, lightheaded, and nausea (7-10 days)
Symptoms: moderate pain at immunization site, intense itching, body aches, headache, dizziness, fatigue. Signs: fever (100.5*F), erythema (4 inch diameter), swelling, warmth at injection site. Time course: 2 days (ongoing). Treatment: Ice massage at injection site, ibuprofen, diphenhydramine (oral).
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Feb-2021 at 2:19 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 14-Feb-2021 at 2:18 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). In 2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant products were not provided.  Number of vials sent to clinic were 30. Vial moved to fridge on 09-Feb-2021 and beyond use date for these vials was reported as 10-Mar-2021. Vial was moved to clinic on 13-Jan-2021. Batch number 031L20A administered on 14-Feb-201 underwent temperature excursion with temperature of 32 degrees Fahrenheit at 09:00 am, 32 degrees Fahrenheit at 10:00 am, 32 degrees Fahrenheit at 11:00 am, and 35 degrees Fahrenheit at 02:00 and 03:00 pm.  Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34 or 35 degree Fahrenheit. Temperature recordings were taken using a traceable temperature monitor at every hour. No treatment medications were reported.  Treatment products were not provided.
45min post vax pt returned w/reddened, swollen lt eye; MD informed & ordered benadryl-ice applied to the eye; Eye returned to normal appearance w/in ninety min & pt experienced no further sx;
4 days after the first vaccine, my left arm has itchy, hive-like bumps. Day 5, they've begun to spread to my right hand and legs.
My sons arm started swelling at injection point immediately after his injections. The site was hot to touch and three times its normal size. He became lethargic. We immediately called the Dr and were instructed to come back with him. She prescribed antibiotics as well as antihistamines and Motrin. We have been dealing with behavioral issues and severe comprehension issues since these shots. Our son was perfectly healthy and developing at a normal rate prior to this event. The Dr. was incredibly rude to us and more concerned about her vaccination rates than properly reporting this event and the well being of our son.
Condition aggravated; Allergies; Eyes  was burning; Checked  her oxygen and was little low; She slept more; Mild cough; More fatigue/ tiredness; This spontaneous case was reported by a consumer and describes the occurrence of CONDITION AGGRAVATED (Condition aggravated), MULTIPLE ALLERGIES (Allergies), EYE IRRITATION (Eyes  was burning), OXYGEN SATURATION DECREASED (Checked  her oxygen and was little low) and HYPERSOMNIA (She slept more) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040B21A and 044A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included COPD and Seasonal allergy (Patient has nose running constantly, little cough, eyes burning  due to spring.).   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced CONDITION AGGRAVATED (Condition aggravated), MULTIPLE ALLERGIES (Allergies), EYE IRRITATION (Eyes  was burning), OXYGEN SATURATION DECREASED (Checked  her oxygen and was little low), HYPERSOMNIA (She slept more), COUGH (Mild cough) and FATIGUE (More fatigue/ tiredness). At the time of the report, CONDITION AGGRAVATED (Condition aggravated), MULTIPLE ALLERGIES (Allergies), EYE IRRITATION (Eyes  was burning), OXYGEN SATURATION DECREASED (Checked  her oxygen and was little low), HYPERSOMNIA (She slept more), COUGH (Mild cough) and FATIGUE (More fatigue/ tiredness) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Mar-2021, Oxygen saturation: normal (normal) Patient checked her oxygen  level was fine. On 08-Apr-2021, Oxygen saturation: low (Low) After second dose patient oxygen was low.          No treatment information was provided. No relevant concomitant medications were reported.   This case was linked to MOD-2021-080402 (Patient Link).
Product Storage error/doses administered after more than 1 temperature excursion; doses administered after more than 1 temperature excursion during 33 weeks in 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Product Storage error/doses administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (doses administered after more than 1 temperature excursion during 33 weeks in 2021) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 035C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Oct-2021 at 11:42 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 27-Oct-2021 at 11:42 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (doses administered after more than 1 temperature excursion during 33 weeks in 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Product Storage error/doses administered after more than 1 temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Product Storage error/doses administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (doses administered after more than 1 temperature excursion during 33 weeks in 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 78.31. Concomitant products were not provided. On 27-OCT-2021, Excursion time was 09 AM temperature was 29 and 10 AM temperature was 32 total doses given for the day was 116, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 29-SEP-2021 and 05-OCT-2021 respectively, vial was moved to clinic on 27-OCT-2021. 2 and 4 vials were sent to clinic respectively. Vaccine BUD date was 29-OCT-2021 and 04-NOV-2021respectively. On 27-OCT-2021, vials were stored in cooler 1, at following time and temperature respectively, 8 AM: 41, 9 AM: 29, 10 AM: 32, 11 AM: 43, 12 AM: 43, 1PM: 43, 2 PM: 46, 3 PM: 46, 4 PM: 46 and 5 PM: 45. The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic. Temperature recordings were taken using a traceable temperature monitor at every hour. After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature. It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 and half hour approximately, when the temperature data logger registered 34 or 35 degree F. Treatment medications were not reported.
RASH ON BODY NOT FACE/ 100.4 TEMP ON 03/25/2012 PM.
5-6 hours following vaccination, patient noted body aches, chills and progressive left deltoid pain.  By the following morning the patient was noted to have a 2cm2 painful lymph node in the left axilla.  Symptoms lasted approximately 48 hours and the teen was treated with ibuprofen.
Rash both arms, used BENADRYL. No other ill effects. Given at work.
On, 11-22-2016, an HPV vaccine was given in error, it should have been an Hib as the patient was a 10 month old. The mistake was not caught until entering the information into the EHR later that afternoon. Patient was informed, the health department was informed as well as the CDC.
The adverse reaction begin with dizziness, light headiness and increased body temp. Upon being released from vaccine location while driving an allergic reaction occurred causing swelling of the throat, skin change to red and rash like. I called 911 as I had trouble breathing and an ambulance took me to the hospital and administred epinephrine and benadryl. They called it analphlatic shock or extreme allergic reaction.
This spontaneous report was received from a consumer referring to a male patient of unknown age (reported as "mid-30s"). The patient's medical history, concurrent conditions and concomitant therapies were not provided. On 15-FEB-2019 the patient was vaccinated with a dose of PNEUMOVAX 23 (strength, dose, frequency, lot # and expiration date were not reported) and a dose of influenza virus vaccine (unspecified) (INFLUENZA VIRUS VACCINE (UNSPECIFIED)) (strength, route, dose, frequency, lot # and expiration date were not reported) for prophylaxis. On an unknown date in February 2019 the patient experienced an injection site reaction, however there was some confusion as to which injection was received in which arm, so it is unknown which vaccine caused the reaction. Within days he developed myopericarditis, which was originally diagnosed as a heart attack in the emergency room (ER).  The outcome of the events was reported as recovered. Causality was unknown. Upon internal review, myopericarditis was determined to be medically significant.
Patient c/o itching and redness at injection site on left shoulder. Red area 4 cm diameter at injection site. No other complaints cool compress applied redness spread to neck shoulder and cheeks 911 called. They assessed and released patient to parent advised to see pediatrician.